Close

M Halloran

M. Elizabeth Halloran

Faculty Member

Education

Affiliations

Projects

Papers

Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME. (2019). Networks of face-to-face social contacts in Niakhar, Senegal. PLoS One, 14(8)

Basta NE, Halloran ME. (2019). Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design. American journal of epidemiology, 188(6)

Halloran ME, Hudgens MG. (2018). Estimating population effects of vaccination using large, routinely collected data. Statistics in medicine, 37(2)

Gabriel EE, Sachs MC, Halloran ME. (2018). Evaluation and comparison of predictive individual-level general surrogates. Biostatistics (Oxford, England), 19(3)

Halloran ME, Hudgens MG. (2018). Comment on Laber et al. Journal of the Royal Statistical Society. Series C, Applied statistics, 67(4)

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. (2017). Simulations for designing and interpreting intervention trials in infectious diseases. BMC medicine, 15(1)

Zhou J, Chu H, Hudgens MG, Halloran ME. (2016). A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes. Statistics in medicine, 35(1)

Halloran ME, Hudgens MG. (2016). Dependent Happenings: A Recent Methodological Review. Current epidemiology reports, 3(4)

Gabriel EE, Daniels MJ, Halloran ME. (2016). Comparing biomarkers as trial level general surrogates. Biometrics, 72(4)

Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME. (2015). The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiology and infection, 143(16)

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)

Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)

VanderWeele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2014). Interference and Sensitivity Analysis. Statistical science : a review journal of the Institute of Mathematical Statistics, 29(4)

Chao DL, Longini IM Jr., Halloran ME. (2013). The effects of vector movement and distribution in a mathematical model of dengue transmission. PLoS One, 8(10)

Auranen K, Rinta-Kokko H, Halloran ME. (2013). Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study. Biometrics, 69(1)

Halloran ME, Hudgens MG. (2012). Causal inference for vaccine effects on infectiousness. The international journal of biostatistics, 8(2)

Halloran ME. (2012). The Minicommunity Design to Assess Indirect Effects of Vaccination. Epidemiologic methods, 1(1)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2012). ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The annals of applied statistics, 6(1)

Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2012). Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology (Cambridge, Mass.), 23(5)

Halloran ME, Hudgens MG. (2012). Comparing bounds for vaccine effects on infectiousness. Epidemiology (Cambridge, Mass.), 23(6)

Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2011). ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The annals of applied statistics, 5(3)

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)

Halloran ME, Holmes EC. (2009). Invited commentary: Evaluating vaccination programs using genetic sequence data. American journal of epidemiology, 170(12)

Halloran ME. (2009). On influenza and school closings: time for prospective studies. Epidemiology (Cambridge, Mass.), 20(6)

Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P. (2008). Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America, 105(12)

Hudgens MG, Halloran ME. (2008). Toward Causal Inference With Interference. Journal of the American Statistical Association, 103(482)

Yang Y, Gilbert P, Longini IM, Halloran ME. (2008). A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The annals of applied statistics, 2(4)

Halloran ME, Piedra PA, Longini IM Jr., Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. (2007). Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine, 25(20)

Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. (2007). Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American journal of epidemiology, 165(2)

Yang Y, Longini IM, Halloran ME. (2007). A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational statistics & data analysis, 51(12)

Struchiner CJ, Halloran ME. (2007). Randomization and baseline transmission in vaccine field trials. Epidemiology and infection, 135(2)

Yang Y, Longini IM, Halloran ME. (2007). A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The annals of applied statistics, 1(1)

Halloran ME. (2006). Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission. American journal of epidemiology, 164(10)

Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)

Halloran ME. (2006). Overview of vaccine field studies: types of effects and designs. Journal of biopharmaceutical statistics, 16(4)

Yang Y, Longini IM Jr., Halloran ME. (2006). Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied statistics, 55(3)

Hudgens MG, Halloran ME. (2006). Causal Vaccine Effects on Binary Postinfection Outcomes. Journal of the American Statistical Association, 101(473)

Patel R, Longini IM Jr., Halloran ME. (2005). Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of theoretical biology, 234(2)

Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)

Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)

Chu H, Halloran ME. (2004). Estimating vaccine efficacy using auxiliary outcome data and a small validation sample. Statistics in medicine, 23(17)

Chu H, Préziosi MP, Halloran ME. (2004). Estimating heterogeneous transmission with multiple infectives using MCMC methods. Statistics in medicine, 23(1)

Glezen WP, Piedra PA, Longini IM, Halloran ME. (2004). Safety of cold-adapted live influenza vaccine. The Pediatric infectious disease journal, 23(6)

Chu H, Halloran ME. (2004). Bayesian estimation of vaccine efficacy. Clinical trials (London, England), 1(3)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine, 21(17-18)

Halloran ME, Longini IM Jr., Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. (2003). Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. American journal of epidemiology, 158(4)

Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(6)

Halloran ME, Longini IM Jr., Nizam A, Yang Y. (2002). Containing bioterrorist smallpox. Science (New York, N.Y.), 298(5597)

Halloran ME, Longini IM, Cowart DM, Nizam A. (2002). Community interventions and the epidemic prevention potential. Vaccine, 20(27-28)

Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)

Halloran ME, Longini IM Jr., Struchiner CJ. (1999). Design and interpretation of vaccine field studies. Epidemiologic reviews, 21(1)

Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)

Stephens DS, Levin B, Halloran ME. (1998). Symposium on population biology, evolution, and control of infectious diseases. Introduction. The American journal of the medical sciences, 315(2)

Halloran ME, Anderson RM, Azevedo-Neto RS, Bellini WJ, Branch O, Burke MA, Compans R, Day K, Gooding L, Gupta S, Katz J, Kew O, Keyserling H, Krause R, Lal AA, Massad E, McLean AR, Rosa P, Rota P, Wiener P, Wynn SG, Zanetta DM. (1998). Population biology, evolution, and immunology of vaccination and vaccination programs. The American journal of the medical sciences, 315(2)

Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)

Bertolli J, Pangi C, Frerichs R, Halloran ME. (1997). A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. International journal of epidemiology, 26(4)

Mosure DJ, Berman S, Kleinbaum D, Halloran ME. (1996). Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. American journal of epidemiology, 144(10)

Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)

Antia R, Halloran ME. (1996). Recent developments in theories of pathogenesis of AIDS. Trends in microbiology, 4(7)

Halloran ME, Longini IM Jr., Struchiner CJ. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American journal of epidemiology, 144(1)

Halloran ME. (1996). Epidemiologic effects of varicella vaccination. Infectious disease clinics of North America, 10(3)

Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)

Haber M, Watelet L, Halloran ME. (1995). On individual and population effectiveness of vaccination. International journal of epidemiology, 24(6)

Halloran ME, Struchiner CJ. (1995). Causal inference in infectious diseases. Epidemiology (Cambridge, Mass.), 6(2)

Noronha CP, Struchiner CJ, Halloran ME. (1995). Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. International journal of epidemiology, 24(5)

Halloran ME, Longini IM Jr., Haber MJ, Struchiner CJ, Brunet RC. (1994). Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Statistics in medicine, 13(4)

Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. (1994). Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American journal of epidemiology, 140(2)

Halloran ME. (1994). Mycobacterium tuberculosis: just desserts for an ungrateful guest. Trends in ecology & evolution, 9(2)

Halloran ME, Watelet L, Struchiner CJ. (1994). Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Mathematical biosciences, 121(2)

Devine OJ, Louis TA, Halloran ME. (1994). Empirical Bayes methods for stabilizing incidence rates before mapping. Epidemiology (Cambridge, Mass.), 5(6)

Halloran ME. (1993). Salmonella enteritidis infections in France and the United States: causes vs causal models. American journal of public health, 83(12)

Brunet RC, Struchiner CJ, Halloran ME. (1993). On the distribution of vaccine protection under heterogeneous response. Mathematical biosciences, 116(1)

Schapira A, Beales PF, Halloran ME. (1993). Malaria: living with drug resistance. Parasitology today (Personal ed.), 9(5)

Halloran ME. (1992). Persistence, drugs and rock'n'roll. Trends in ecology & evolution, 7(7)

Halloran ME, Struchiner CJ. (1992). Modeling transmission dynamics of stage-specific malaria vaccines. Parasitology today (Personal ed.), 8(3)

Struchiner CJ, Halloran ME. (1992). Modeling AIDS vaccines: the cellular level. Memorias do Instituto Oswaldo Cruz, 87(1)

Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)

Halloran ME, Haber M, Longini IM Jr., Struchiner CJ. (1991). Direct and indirect effects in vaccine efficacy and effectiveness. American journal of epidemiology, 133(4)

Halloran ME, Struchiner CJ. (1991). Study designs for dependent happenings. Epidemiology (Cambridge, Mass.), 2(5)

Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)

Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)

Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)

Halloran ME, Struchiner CJ, Spielman A. (1989). Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Mathematical biosciences, 94(1)

Halloran ME, Bundy DA, Pollitt E. (1989). Infectious disease and the Unesco basic education initiative. Parasitology today (Personal ed.), 5(11)